Daniel Rader
Dr. Daniel Rader is a preventive cardiologist and a prominent researcher at the Perelman School of Medicine at the University of Pennsylvania. He is recognized for his contributions to understanding lipid metabolism and cardiovascular risk factors. Rader serves on the scientific advisory board for Novartis and has been vocal about the exciting advancements in treatments targeting lipoprotein(a), describing the reduction of Lp(a) levels as a significant breakthrough in cardiovascular medicine.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 8.00 | 0.04% | +0% | 211,049,527 | 88,416 | $1,500,000 | 628$ |
| Totals | 1 | 211,049,527 | 88,416 | $1,500,000 | 628$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Daniel Rader is a preventive cardiologist who stated that the reduction of Lp(a) is a new and huge frontier in cardiovascular medicine.
8